XML 26 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net income (loss) $ 165,970 $ (997,742)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 75,617 116,117
Amortization of operating lease right-of-use assets 35,797 68,229
Loss on impairment of assets 68,429 782,526
(Gain) loss on sales and disposal of subsidiaries and property and equipment, net (625,532) 524,956
Loss on derivative instruments 24,517 626
Payments for settlement of derivative contracts 0 (626)
Loss on debt extinguishment 77,999 0
Non-cash interest expense 6,129 14,075
Interest paid on deferred purchase price for acquisitions 0 (3,969)
Non-cash share-based compensation expense 7,175 10,277
Bad debt expense 17,672 97,662
Deferred income taxes 267,551 (264,381)
Unrealized foreign currency exchange gain (11,240) (15,355)
Non-cash loss from non-income tax contingencies 11,976 3,375
Other, net (71) 1,917
Changes in operating assets and liabilities:    
Receivables (9,632) (325,106)
Prepaid expenses and other assets (20,021) (47,616)
Accounts payable and accrued expenses (47,175) (50,545)
Income tax receivable/payable, net 63,151 (56,875)
Deferred revenue and other liabilities (54,272) 364,210
Net cash provided by operating activities 54,040 221,755
Cash flows from investing activities    
Purchase of property and equipment (27,578) (62,347)
Expenditures for deferred costs (5,371) (11,955)
Receipts from sales of discontinued operations, net of cash sold, and property and equipment 2,137,673 40,148
Payments on derivatives related to sale of discontinued operations (50,341) 0
Payments to related parties 0 (3)
Net cash provided by (used in) investing activities 2,054,383 (34,157)
Cash flows from financing activities    
Proceeds from issuance of long-term debt, net of original issue discount 46,493 566,726
Payments on long-term debt (933,213) (298,664)
Payments of deferred purchase price for acquisitions 0 (5,680)
Proceeds from exercise of stock options 1,160 26,697
Withholding of shares to satisfy tax withholding for vested stock awards and exercised stock options (1,718) (1,150)
Payments to repurchase common stock (364,275) (29,203)
Payments of call premiums and debt issuance costs (32,980) (726)
Distributions to noncontrolling interest holders 0 (609)
Net cash (used in) provided by financing activities (1,284,533) 257,391
Effects of exchange rate changes on Cash and cash equivalents and Restricted cash (14,360) (13,448)
Change in cash included in current assets held for sale 285,027 218,298
Net change in Cash and cash equivalents and Restricted cash 1,094,557 649,839
Cash and cash equivalents and Restricted cash at beginning of period 867,298 97,817
Cash and cash equivalents and Restricted cash at end of period $ 1,961,855 $ 747,656